The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3S)-3-cyclopropyl-3-[3-[[6-(5,5-dimethylcyclopenten-1-yl)-5-(5-fluoro-2-methoxy-4-pyridyl)pyrazin-2-yl]methoxy]phenyl]propanoic acid ID: ALA4764729
PubChem CID: 118645715
Max Phase: Preclinical
Molecular Formula: C30H32FN3O4
Molecular Weight: 517.60
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(-c2ncc(COc3cccc([C@@H](CC(=O)O)C4CC4)c3)nc2C2=CCCC2(C)C)c(F)cn1
Standard InChI: InChI=1S/C30H32FN3O4/c1-30(2)11-5-8-24(30)29-28(23-13-26(37-3)32-16-25(23)31)33-15-20(34-29)17-38-21-7-4-6-19(12-21)22(14-27(35)36)18-9-10-18/h4,6-8,12-13,15-16,18,22H,5,9-11,14,17H2,1-3H3,(H,35,36)/t22-/m0/s1
Standard InChI Key: NEANWAJDBGJJSW-QFIPXVFZSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
4.4822 -16.1829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2717 -16.9753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0632 -16.7614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0709 -18.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0698 -19.0247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7820 -19.4378 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4958 -19.0242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4929 -18.1974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7802 -17.7922 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3597 -17.7889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4759 -16.8054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0665 -17.5127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6128 -18.1205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1986 -17.7853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9083 -18.1904 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 -19.4324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6553 -19.0209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9473 -19.4276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9455 -20.2456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6575 -20.6553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 -20.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0706 -20.6541 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.2405 -19.0174 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2423 -18.2002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6140 -17.7782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3211 -18.1855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0263 -17.7740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0226 -16.9560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3079 -16.5511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6057 -16.9649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7358 -18.1794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4417 -17.7676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1512 -18.1730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8571 -17.7612 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1549 -18.9902 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7395 -18.9966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3374 -19.7074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1545 -19.7037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 2 1 0
2 11 1 0
11 12 1 0
12 13 1 0
13 10 2 0
4 10 1 0
8 14 1 0
14 15 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
5 16 1 0
21 22 1 0
18 23 1 0
23 24 1 0
15 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
27 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
33 35 2 0
31 36 1 1
37 36 1 0
38 37 1 0
36 38 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 517.60Molecular Weight (Monoisotopic): 517.2377AlogP: 6.44#Rotatable Bonds: 10Polar Surface Area: 94.43Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.92CX Basic pKa: 0.56CX LogP: 5.59CX LogD: 2.39Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -0.07
References 1. Meegalla SK,Huang H,Martin T,Xu J,Zhao S,Liu J,Hall M,Gunnet J,Wang Y,Rady B,Silva J,Otieno M,Arnoult E,Paul Lee S,Pocai A,Player MR. (2018) Discovery of a novel potent GPR40 full agonist., 28 (4): [PMID:29366647 ] [10.1016/j.bmcl.2018.01.013 ]